2-ethylamino-1,3,4-thiadiazole

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Hemorrhagic Shock 01/01/1980 - "Effects of 2-ethylamino-1,3,4-thiadiazole on hepatic adenosine nucleotides in experimental hemorrhagic shock."
2.	Neoplasms (Cancer) 01/01/1980 - "2-Ethylamino-1,3,4-thiadiazole (EAT), originally tested as a cancer chemotherapeutic agent, has been shown to increase the de novo synthesis of purines. "